Stay informed on the novel Coronavirus (Covid-19)

Keep abreast of coronavirus and its ongoing impact on markets and the economy. The situation remains fluid, so we plan to update this page regularly.

Featured Content

Special Edition Covid-19 Podcast

Keeping Calm in a Covid Correction

April 9, 2020

The speed and magnitude of stocks’ decline has been incredibly unnerving. Our latest podcast suggests the most important action you can take to navigate today’s turmoil.

Listen to Podcast »

AB Bernstein Head David Barnard

Our Commitment to You Amid Covid-19

Amidst an unprecedented level of uncertainty and anxiety, Bernstein Head David Barnard reaffirms our commitment to serving you.

View Video »

AB Bernstein, Chief US Economist, Eric Winograd

Three Key Channels That Are Moving Markets

April 9, 2020

While it’s difficult to forecast what lies ahead, our Chief US Economist, Eric Winograd, sees encouraging signs along three key channels: public health, central bank policy, and fiscal relief.

View Video »

Timely Questions

Our investment professionals respond to the most frequently asked questions we’re hearing right now.

What’s the Best Way to Manage Risk Now?

April 9, 2020

How can you defend against turbulence while positioning for an eventual rebound? The answer: Be ready to adapt—and to do it quickly.

Read More »

Should I Forge Ahead Despite Uncertainty?

April 2, 2020

Is now a good time to wade into the market—or wait on the sidelines for the crisis to pass? We found decisive action pays.

Read More »

How Long Will It Take for Markets to Recover?

March 30, 2020

Two questions are top of mind for many investors now: Should I retreat from equities and how long will it take for the markets to recover?

Read More »

Why Should Donors and Nonprofits Care About the Stimulus Bill?

March 27, 2020

The $2 trillion fiscal stimulus encourages giving while providing welcome relief for nonprofits starved for funds.

Read More »

Keeping in Touch

Bond Market Update

The Sum of All Fears—Dave Barnard’s Quarterly Letter

March 31, 2020

Dave explains some of the structural factors that accelerated the unwind, and what gives him hope as he looks ahead.

Continue Reading »

Gaining Industry Perspectives

Pharma Races to Respond

Pharma Races to Respond

Bernstein research analyst Ronny Gal talks about the race to develop therapies, the prospects for a vaccine, and accelerated data sharing in the scientific community.

Listen to Podcast »

Widening the Lens

Alligtor in Water

The Hidden Cost of Market Timing

A dispassionate look at the math (and futility) of market timing—as well as how proactive planning helps resist the urge.

Download the Article »

The information presented and opinions expressed are solely the views of the authors. AllianceBernstein L.P. or its affiliates makes no representations or warranties concerning the accuracy of any data. There is no guarantee that any projection, forecast or opinion in this material will be realized. Past performance does not guarantee future results. The views expressed here may change at any time after the date of this material. This is for informational purposes only and does not constitute investment advice. AllianceBernstein L.P. does not provide tax, legal or accounting advice. It does not take an investor’s personal investment objectives or financial situation into account; investors should discuss their individual circumstances with appropriate professionals before making any decisions. This information should not be construed as sales or marketing material or an offer or solicitation for the purchase or sale of any financial instrument, product or service sponsored by AllianceBernstein or its affiliates. The [A/B] logo is a registered service mark of AllianceBernstein, and AllianceBernstein® is a registered service mark, used by permission of the owner, AllianceBernstein L.P.

© 2020 AllianceBernstein L.P.